SK

Shubh Karan Dewan

Director Director DIN 08331474
DIN 08331474 First appointment Jan 2019 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jan 2019
Shareholding value Locked Premium profile

About Shubh Karan Dewan

Data last updated:

Shubh Karan Dewan has 7 years in corporate governance. Formerly with 1 company, such as Acusoma Healthcare Limited. Engaged in Healthcare. Contributes to corporate operations.

DIN 08331474
Primary Designation Director
First Appointment 15 Jan 2019
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Acusoma Healthcare Limited U85310DL2019PLC344397
Director15 Jan 20192019Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Acusoma Healthcare Limited
Premium access

Shareholding and investment profile for Shubh Karan Dewan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shubh Karan Dewan

Shubh Karan Dewan has 7 years in corporate governance. Formerly with 1 company, such as Acusoma Healthcare Limited. Engaged in Healthcare. Contributes to corporate operations.

Shubh Karan Dewan is associated with 0 companies as a director.

Shubh Karan Dewan has expertise in Healthcare.

Shubh Karan Dewan has 7 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available